Highlands Oncology Group SC

Fayetteville, Arkansas 72703

0 studies enrolling now · 2 studies all time

What they study most

Early Breast Cancer, Tumor Pathway Activations Inhibited by Dovitinib

Studies at this site

• Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib — Completed
• A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1) — Stopped early